sulpiride has been researched along with Cannabis Abuse in 2 studies
Sulpiride: A dopamine D2-receptor antagonist. It has been used therapeutically as an antidepressant, antipsychotic, and as a digestive aid. (From Merck Index, 11th ed)
sulpiride : A member of the class of benzamides obtained from formal condensation between the carboxy group of 2-methoxy-5-sulfamoylbenzoic acid and the primary amino group of (1-ethylpyrrolidin-2-yl)methylamine.
Excerpt | Relevance | Reference |
---|---|---|
"Schizophrenia is a mental illness causing disordered beliefs, ideas and sensations." | 2.50 | Cannabis and schizophrenia. ( Gillies, D; Kalakouti, E; Kyprianou, K; McLoughlin, BC; Pushpa-Rajah, JA; Rathbone, J; Variend, H, 2014) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gray, KM | 1 |
Sonne, SC | 1 |
McClure, EA | 1 |
Ghitza, UE | 1 |
Matthews, AG | 1 |
McRae-Clark, AL | 1 |
Carroll, KM | 1 |
Potter, JS | 1 |
Wiest, K | 1 |
Mooney, LJ | 1 |
Hasson, A | 1 |
Walsh, SL | 1 |
Lofwall, MR | 1 |
Babalonis, S | 1 |
Lindblad, RW | 1 |
Sparenborg, S | 1 |
Wahle, A | 1 |
King, JS | 1 |
Baker, NL | 1 |
Tomko, RL | 1 |
Haynes, LF | 1 |
Vandrey, RG | 1 |
Levin, FR | 1 |
McLoughlin, BC | 1 |
Pushpa-Rajah, JA | 1 |
Gillies, D | 1 |
Rathbone, J | 1 |
Variend, H | 1 |
Kalakouti, E | 1 |
Kyprianou, K | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
A Pilot Study of N-acetylcysteine for Alcohol Use Disorder[NCT04964843] | Phase 2 | 0 participants (Actual) | Interventional | 2023-04-30 | Withdrawn (stopped due to Null results were posted from a neurometabolite study and a recent trial for AUD. Study may resume if more positive data emerge.) | ||
Achieving Cannabis Cessation: Evaluating N-Acetylcysteine Treatment (ACCENT)[NCT01675661] | Phase 3 | 302 participants (Actual) | Interventional | 2014-01-31 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
The primary outcome is the abstinence rate over the 12 weeks of treatment. Abstinence is based on a weekly urine drug screen confirmed by central laboratory testing and defined as a negative cannabinoid result. (NCT01675661)
Timeframe: study weeks 2-13
Intervention | cannabis negative urine tests (Number) | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Study Week 2 | Study Week 3 | Study Week 4 | Study Week 5 | Study Week 6 | Study Week 7 | Study Week 8 | Study Week 9 | Study Week 10 | Study Week 11 | Study Week 12 | Study Week 13 | Overall | |
NAC Plus CM | 25 | 30 | 33 | 32 | 32 | 36 | 40 | 39 | 39 | 38 | 34 | 33 | 410 |
Placebo Plus CM | 21 | 22 | 36 | 33 | 30 | 37 | 37 | 36 | 37 | 36 | 40 | 36 | 401 |
1 review available for sulpiride and Cannabis Abuse
Article | Year |
---|---|
Cannabis and schizophrenia.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Cannabinoids; Humans; Marijuana Abuse; Medical M | 2014 |
1 trial available for sulpiride and Cannabis Abuse
Article | Year |
---|---|
A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults.
Topics: Acetylcysteine; Adolescent; Adult; Cannabis; Double-Blind Method; Female; Free Radical Scavengers; H | 2017 |
A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults.
Topics: Acetylcysteine; Adolescent; Adult; Cannabis; Double-Blind Method; Female; Free Radical Scavengers; H | 2017 |
A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults.
Topics: Acetylcysteine; Adolescent; Adult; Cannabis; Double-Blind Method; Female; Free Radical Scavengers; H | 2017 |
A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults.
Topics: Acetylcysteine; Adolescent; Adult; Cannabis; Double-Blind Method; Female; Free Radical Scavengers; H | 2017 |